Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaning He

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Zhonghua Yi Xue Za Zhi|December 30, 2015
[Associations between TOX3 rs3803662 polymorphisms and immunological markers of breast cancer]Qi Chen, Yaning He, Chaojun Liu, et al.
European Journal of Gynaecological Oncology|January 9, 2015
Screening of the miRNAs related to breast cancer and identification of its target genesXianfu Sun, Suxia Luo, Yaning He, et al.
Frontiers in Endocrinology|September 5, 2022
HER2-low expression does not affect the clinical outcomes of metastatic breast cancer treated with CDK4/6 inhibitor: A real-world studyYingbo Shao, Zhifen Luo, Yang Yu, et al.
Frontiers in Oncology|August 15, 2022
A real-world study of anlotinib as third-line or above therapy in patients with her-2 negative metastatic breast cancerYingbo Shao, Zhifen Luo, Yang Yu, et al.
Breast (Edinburgh, Scotland)|December 30, 2023
Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapyYingbo Shao, Huijuan Guan, Zhifen Luo, et al.
International Journal of Biological Macromolecules|September 10, 2019
Adsorption behavior of heavy metal ions from aqueous solution onto composite dextran-chitosan macromolecule resin adsorbentYang Liu, Lishuang Hu, Bo Tan, et al.
Frontiers in Oncology|March 20, 2025
Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapyYingbo Shao, Huijuan Guan, Zhifen Luo, et al.
Annals of Surgical Oncology|August 6, 2022
Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective AnalysisYingbo Shao, Yang Yu, Zhifen Luo, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Zhonghua Yi Xue Za Zhi|December 30, 2015
[Associations between TOX3 rs3803662 polymorphisms and immunological markers of breast cancer]Qi Chen, Yaning He, Chaojun Liu, et al.
European Journal of Gynaecological Oncology|January 9, 2015
Screening of the miRNAs related to breast cancer and identification of its target genesXianfu Sun, Suxia Luo, Yaning He, et al.
Frontiers in Endocrinology|September 5, 2022
HER2-low expression does not affect the clinical outcomes of metastatic breast cancer treated with CDK4/6 inhibitor: A real-world studyYingbo Shao, Zhifen Luo, Yang Yu, et al.
Frontiers in Oncology|August 15, 2022
A real-world study of anlotinib as third-line or above therapy in patients with her-2 negative metastatic breast cancerYingbo Shao, Zhifen Luo, Yang Yu, et al.
Breast (Edinburgh, Scotland)|December 30, 2023
Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapyYingbo Shao, Huijuan Guan, Zhifen Luo, et al.
International Journal of Biological Macromolecules|September 10, 2019
Adsorption behavior of heavy metal ions from aqueous solution onto composite dextran-chitosan macromolecule resin adsorbentYang Liu, Lishuang Hu, Bo Tan, et al.
Frontiers in Oncology|March 20, 2025
Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapyYingbo Shao, Huijuan Guan, Zhifen Luo, et al.
Annals of Surgical Oncology|August 6, 2022
Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective AnalysisYingbo Shao, Yang Yu, Zhifen Luo, et al.
Pageof 5